Sarepta Therapeutics Inc (SRPT)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -535,977 | -703,488 | -418,780 | -554,128 | -715,075 |
| Revenue | US$ in thousands | 1,243,340 | 933,013 | 701,887 | 540,099 | 380,833 |
| Net profit margin | -43.11% | -75.40% | -59.66% | -102.60% | -187.77% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-535,977K ÷ $1,243,340K
= -43.11%
Sarepta Therapeutics Inc's net profit margin has shown a fluctuating trend over the past five years. The company experienced negative net profit margins in all the years, with the margins ranging from -187.77% in 2019 to -43.11% in 2023.
The net profit margin indicates the company's ability to generate profit from its revenue after accounting for all expenses. The consistently negative net profit margins suggest that Sarepta Therapeutics Inc has been unable to generate sustainable profits relative to its revenue in recent years.
The increasing trend in the net profit margin from 2019 to 2023 indicates some improvement in the company's profitability performance, although it remains in negative territory. However, further analysis of the company's cost structure, revenue growth, and potential efficiency improvements may be necessary to understand the factors contributing to these negative profit margins.
Peer comparison
Dec 31, 2023